Despite a lengthier process than expected within the Indian Ministry of Health in the registration of SciGen's insulin in India, the process is now well under way and expected to conclude in the middle
of this year with sales expected to commence in early FY 04 which is later than originally anticipated.
sie - india deal postponed -- disappointing
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)